Post-operative Nausea And Vomiting Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Postoperative nausea and vomiting (PONV) is complex and most commonly seen problem after a patient is recovering from anesthesia. In some cases, it resolves without sequelae, and in some cases, it may require unexpected hospital admission and delayed recovery room discharge. The worse PONV may further lead to increased intracranial pressure, wound dehiscence, aspiration, esophageal rupture, dehydration, and pneumothorax.
MARKET DYNAMICS
The post-operative nausea and vomiting market growth is estimated to grow due to the increasing surgeries for chronic diseases, infection and health conditions, growing adoption generic medicines to treat nausea and vomiting, and rising sales of OTC products. The growing awareness about the non-pharmaceutical treatment is likely to create vital growth opportunities for the market.
MARKET SCOPE
The "Post-operative Nausea and Vomiting Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of post-operative nausea and vomiting market with detailed market segmentation by treatment type, and distribution channel. The post-operative nausea and vomiting market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in post-operative nausea and vomiting market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The post-operative nausea and vomiting market is segmented on the basis of treatment type, and distribution channel. Based on treatment type, the market is classified as post-operative nausea and vomiting, and non-pharmacological treatment. And on the basis of distribution channel, the market is segmented as hospital and retails pharmacies, online distribution, hyper and super markets.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the post-operative nausea and vomiting market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The post-operative nausea and vomiting market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting post-operative nausea and vomiting market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the post-operative nausea and vomiting market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the post-operative nausea and vomiting market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The post-operative nausea and vomiting market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting post-operative nausea and vomiting market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the post-operative nausea and vomiting market in these regions.
MARKET PLAYERS
The report covers key developments in the post-operative nausea and vomiting market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from post-operative nausea and vomiting market are anticipated to have lucrative growth opportunities in the future with the rising demand for post-operative nausea and vomiting market in the global market. Below mentioned is the list of few companies engaged in the post-operative nausea and vomiting market.
The report also includes the profiles of key players in post-operative nausea and vomiting market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Novartis AG
- GlaxoSmithKline plc
- Merck and Co., Inc
- Pfizer, Inc.
- Bayer AG
- AstraZeneca
- AbbVie
- Sanofi
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Teva Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Post-operative Nausea And Vomiting Market - By Treatment Type
1.3.2 Post-operative Nausea And Vomiting Market - By Distribution Channel
1.3.3 Post-operative Nausea And Vomiting Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. POST-OPERATIVE NAUSEA AND VOMITING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. POST-OPERATIVE NAUSEA AND VOMITING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. POST-OPERATIVE NAUSEA AND VOMITING MARKET - GLOBAL MARKET ANALYSIS
6.1. POST-OPERATIVE NAUSEA AND VOMITING - GLOBAL MARKET OVERVIEW
6.2. POST-OPERATIVE NAUSEA AND VOMITING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. POST-OPERATIVE NAUSEA AND VOMITING MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. POST-OPERATIVE NAUSEA AND VOMITING
7.3.1. Overview
7.3.2. Post-operative Nausea and Vomiting Market Forecast and Analysis
7.3.3. Serotonin Antagonists Market
7.3.3.1. Overview
7.3.3.2. Serotonin Antagonists Market Forecast and Analysis
7.3.4. Steroids Market
7.3.4.1. Overview
7.3.4.2. Steroids Market Forecast and Analysis
7.3.5. Dopamine Antagonists Market
7.3.5.1. Overview
7.3.5.2. Dopamine Antagonists Market Forecast and Analysis
7.3.6. NK-1 Receptor Antagonists Market
7.3.6.1. Overview
7.3.6.2. NK-1 Receptor Antagonists Market Forecast and Analysis
7.3.7. Others Market
7.3.7.1. Overview
7.3.7.2. Others Market Forecast and Analysis
7.4. NON-PHARMACOLOGICAL TREATMENT
7.4.1. Overview
7.4.2. Non-pharmacological Treatment Market Forecast and Analysis
8. POST-OPERATIVE NAUSEA AND VOMITING MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL AND RETAILS PHARMACIES
8.3.1. Overview
8.3.2. Hospital and Retails Pharmacies Market Forecast and Analysis
8.4. ONLINE DISTRIBUTION
8.4.1. Overview
8.4.2. Online Distribution Market Forecast and Analysis
8.5. HYPER AND SUPER MARKETS
8.5.1. Overview
8.5.2. Hyper and Super Markets Market Forecast and Analysis
9. POST-OPERATIVE NAUSEA AND VOMITING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Post-operative Nausea And Vomiting Market Overview
9.1.2 North America Post-operative Nausea And Vomiting Market Forecasts and Analysis
9.1.3 North America Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Countries
9.1.5.1 United States Post-operative Nausea And Vomiting Market
9.1.5.1.1 United States Post-operative Nausea And Vomiting Market by Treatment Type
9.1.5.1.2 United States Post-operative Nausea And Vomiting Market by Distribution Channel
9.1.5.2 Canada Post-operative Nausea And Vomiting Market
9.1.5.2.1 Canada Post-operative Nausea And Vomiting Market by Treatment Type
9.1.5.2.2 Canada Post-operative Nausea And Vomiting Market by Distribution Channel
9.1.5.3 Mexico Post-operative Nausea And Vomiting Market
9.1.5.3.1 Mexico Post-operative Nausea And Vomiting Market by Treatment Type
9.1.5.3.2 Mexico Post-operative Nausea And Vomiting Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Post-operative Nausea And Vomiting Market Overview
9.2.2 Europe Post-operative Nausea And Vomiting Market Forecasts and Analysis
9.2.3 Europe Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Post-operative Nausea And Vomiting Market
9.2.5.1.1 Germany Post-operative Nausea And Vomiting Market by Treatment Type
9.2.5.1.2 Germany Post-operative Nausea And Vomiting Market by Distribution Channel
9.2.5.2 France Post-operative Nausea And Vomiting Market
9.2.5.2.1 France Post-operative Nausea And Vomiting Market by Treatment Type
9.2.5.2.2 France Post-operative Nausea And Vomiting Market by Distribution Channel
9.2.5.3 Italy Post-operative Nausea And Vomiting Market
9.2.5.3.1 Italy Post-operative Nausea And Vomiting Market by Treatment Type
9.2.5.3.2 Italy Post-operative Nausea And Vomiting Market by Distribution Channel
9.2.5.4 Spain Post-operative Nausea And Vomiting Market
9.2.5.4.1 Spain Post-operative Nausea And Vomiting Market by Treatment Type
9.2.5.4.2 Spain Post-operative Nausea And Vomiting Market by Distribution Channel
9.2.5.5 United Kingdom Post-operative Nausea And Vomiting Market
9.2.5.5.1 United Kingdom Post-operative Nausea And Vomiting Market by Treatment Type
9.2.5.5.2 United Kingdom Post-operative Nausea And Vomiting Market by Distribution Channel
9.2.5.6 Rest of Europe Post-operative Nausea And Vomiting Market
9.2.5.6.1 Rest of Europe Post-operative Nausea And Vomiting Market by Treatment Type
9.2.5.6.2 Rest of Europe Post-operative Nausea And Vomiting Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Post-operative Nausea And Vomiting Market Overview
9.3.2 Asia-Pacific Post-operative Nausea And Vomiting Market Forecasts and Analysis
9.3.3 Asia-Pacific Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Post-operative Nausea And Vomiting Market
9.3.5.1.1 Australia Post-operative Nausea And Vomiting Market by Treatment Type
9.3.5.1.2 Australia Post-operative Nausea And Vomiting Market by Distribution Channel
9.3.5.2 China Post-operative Nausea And Vomiting Market
9.3.5.2.1 China Post-operative Nausea And Vomiting Market by Treatment Type
9.3.5.2.2 China Post-operative Nausea And Vomiting Market by Distribution Channel
9.3.5.3 India Post-operative Nausea And Vomiting Market
9.3.5.3.1 India Post-operative Nausea And Vomiting Market by Treatment Type
9.3.5.3.2 India Post-operative Nausea And Vomiting Market by Distribution Channel
9.3.5.4 Japan Post-operative Nausea And Vomiting Market
9.3.5.4.1 Japan Post-operative Nausea And Vomiting Market by Treatment Type
9.3.5.4.2 Japan Post-operative Nausea And Vomiting Market by Distribution Channel
9.3.5.5 South Korea Post-operative Nausea And Vomiting Market
9.3.5.5.1 South Korea Post-operative Nausea And Vomiting Market by Treatment Type
9.3.5.5.2 South Korea Post-operative Nausea And Vomiting Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Post-operative Nausea And Vomiting Market
9.3.5.6.1 Rest of Asia-Pacific Post-operative Nausea And Vomiting Market by Treatment Type
9.3.5.6.2 Rest of Asia-Pacific Post-operative Nausea And Vomiting Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Post-operative Nausea And Vomiting Market Overview
9.4.2 Middle East and Africa Post-operative Nausea And Vomiting Market Forecasts and Analysis
9.4.3 Middle East and Africa Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Post-operative Nausea And Vomiting Market
9.4.5.1.1 South Africa Post-operative Nausea And Vomiting Market by Treatment Type
9.4.5.1.2 South Africa Post-operative Nausea And Vomiting Market by Distribution Channel
9.4.5.2 Saudi Arabia Post-operative Nausea And Vomiting Market
9.4.5.2.1 Saudi Arabia Post-operative Nausea And Vomiting Market by Treatment Type
9.4.5.2.2 Saudi Arabia Post-operative Nausea And Vomiting Market by Distribution Channel
9.4.5.3 U.A.E Post-operative Nausea And Vomiting Market
9.4.5.3.1 U.A.E Post-operative Nausea And Vomiting Market by Treatment Type
9.4.5.3.2 U.A.E Post-operative Nausea And Vomiting Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Post-operative Nausea And Vomiting Market
9.4.5.4.1 Rest of Middle East and Africa Post-operative Nausea And Vomiting Market by Treatment Type
9.4.5.4.2 Rest of Middle East and Africa Post-operative Nausea And Vomiting Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Post-operative Nausea And Vomiting Market Overview
9.5.2 South and Central America Post-operative Nausea And Vomiting Market Forecasts and Analysis
9.5.3 South and Central America Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Post-operative Nausea And Vomiting Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Post-operative Nausea And Vomiting Market
9.5.5.1.1 Brazil Post-operative Nausea And Vomiting Market by Treatment Type
9.5.5.1.2 Brazil Post-operative Nausea And Vomiting Market by Distribution Channel
9.5.5.2 Argentina Post-operative Nausea And Vomiting Market
9.5.5.2.1 Argentina Post-operative Nausea And Vomiting Market by Treatment Type
9.5.5.2.2 Argentina Post-operative Nausea And Vomiting Market by Distribution Channel
9.5.5.3 Rest of South and Central America Post-operative Nausea And Vomiting Market
9.5.5.3.1 Rest of South and Central America Post-operative Nausea And Vomiting Market by Treatment Type
9.5.5.3.2 Rest of South and Central America Post-operative Nausea And Vomiting Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL POST-OPERATIVE NAUSEA AND VOMITING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. POST-OPERATIVE NAUSEA AND VOMITING MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK AND CO., INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAYER AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ABBVIE
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Novartis AG
2. GlaxoSmithKline plc
3. Merck and Co., Inc
4. Pfizer, Inc.
5. Bayer AG
6. AstraZeneca
7. AbbVie
8. Sanofi
9. Boehringer Ingelheim Pharmaceuticals, Inc.
10. Teva Pharmaceutical Industries Ltd
11. Amneal Pharmaceuticals LLC
12. Apotex Corp.
13. Mylan Pharmaceuticals Inc.
14. ANI Pharmaceuticals, Inc.
15. NorthStar Rx LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For